Aripiprazole/dantrolene/lorazepamNeuroleptic malignant syndrome and lack of effect: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1795卷 / 1期

关键词：

D O I：

10.1007/s40278-020-76069-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：48 / 48

相关论文

共 50 条

[41] Aripiprazole/haloperidol decanoateNeuroleptic malignant syndrome and reversible splenial lesion syndrome: case report
Reactions Weekly, 2019, 1735 (1) : 46 - 46
[42] Aripiprazole/quetiapineHiccups and lack of efficacy: case report
Reactions Weekly, 2020, 1829 (1) : 83 - 83
[43] Aripiprazole/bupropionNeutropenia and lack of efficacy: case report
Reactions Weekly, 2021, 1838 (1) : 78 - 78
[44] Aripiprazole/creatine monohydrate/risperidoneNeuroleptic malignant syndrome and weight gain: case report
Reactions Weekly, 2020, 1803 (1) : 52 - 52
[45] Multiple drugsNeuroleptic malignant syndrome and lack of efficacy: case report
Reactions Weekly, 2022, 1911 (1) : 309 - 309
[46] Multiple drugsNeuroleptic malignant syndrome and lack of efficacy : case report
Reactions Weekly, 2023, 1959 (1) : 471 - 471
[47] Risperidone/SertralineNeuroleptic malignant syndrome and lack of efficacy: case report
Reactions Weekly, 2024, 2038 (1) : 294 - 294
[48] Multiple drugsNeuroleptic malignant syndrome and lack of efficacy: case report
Reactions Weekly, 2022, 1913 (1) : 326 - 326
[49] Lorazepam/quetiapineNeuroleptic malignant syndrome and lack of efficacy: case report
Reactions Weekly, 2022, 1929 (1) : 382 - 382
[50] Multiple drugsNeuroleptic malignant syndrome and lack of efficacy: case report
Reactions Weekly, 2022, 1923 (1) : 357 - 357

← 1 2 3 4 5 →